Scienture Holdings Inc
SCNX
View Detailed Chart
0.893USD
+0.004+0.45%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
14.41MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+0.45%
5 Days
-5.34%
1 Month
-20.27%
6 Months
-53.00%
Year to Date
-85.24%
1 Year
-87.67%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated: 2025-09-19Key Insights
The company's fundamentals are relatively weak. Its valuation is considered fairly valued,and institutional recognition is very high. Despite a good stock market performance, the company shows weak fundamentals and technicals, which don't support the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Scienture Holdings, Inc., formerly TRxADE Health, Inc., is a comprehensive health services and pharmaceutical product company focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs, optimize the prescription journey and patient engagement in the United States. It operates through Scienture, LLC and Integra Pharma Solutions, LLC. Scienture, LLC is a branded specialty pharmaceutical company. Its assets in development are across therapeutics areas, indications and cater to different market segments. Its products include SCN - 102 (Cardiovascular), SCN - 104 (CNS-Pain), SCN - 105 (CNS), SCN - 106 (Cardiovascular) and SCN - 107 (Pain). Integra Pharma Solutions, LLC is the pharmaceutical supplier of choice for healthcare organizations of all sizes. Its expertise in the distribution of products extends to all healthcare markets including government organizations, hospitals, clinics, and independent pharmacies nationwide.
Growing
The company is in a growing phase, with the latest annual income totaling USD 136.64K.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD 9.07M.%!(EXTRA int=2)
Overvalued
The company’s latest PE is -0.06, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 4.45M shares, increasing 0.01% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 14.57K shares of this stock.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
Scienture Holdings, Inc., formerly TRxADE Health, Inc., is a comprehensive health services and pharmaceutical product company focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs, optimize the prescription journey and patient engagement in the United States. It operates through Scienture, LLC and Integra Pharma Solutions, LLC. Scienture, LLC is a branded specialty pharmaceutical company. Its assets in development are across therapeutics areas, indications and cater to different market segments. Its products include SCN - 102 (Cardiovascular), SCN - 104 (CNS-Pain), SCN - 105 (CNS), SCN - 106 (Cardiovascular) and SCN - 107 (Pain). Integra Pharma Solutions, LLC is the pharmaceutical supplier of choice for healthcare organizations of all sizes. Its expertise in the distribution of products extends to all healthcare markets including government organizations, hospitals, clinics, and independent pharmacies nationwide.
Ticker SymbolSCNX
CompanyScienture Holdings Inc
CEODr. Narasimhan Mani
Website
Related Instruments
+3.20%
+2.16%
-0.76%
+0.79%
+0.37%
-0.42%
+1.70%
-2.80%
+0.05%
-1.24%
-0.53%
+0.88%
-3.28%
-0.77%
-1.50%
-0.46%
-1.81%
+0.53%
-1.90%
-1.55%
